Zai Lab (ZLAB) Gross Margin (2020 - 2026)

Zai Lab (ZLAB) reported Gross Margin of 844.88% for Q1 2026, down 90849.0% on a YoY basis from N/an in Q1 2025, and down 944.81% sequentially from 100.01% in Q4 2025.

Zai Lab (ZLAB) Gross Margin (2020 - 2026) Analysis & Trends

Zai Lab (ZLAB) has 7 years of Gross Margin data on file, last reported at 844.88% in Q1 2026.

  • For the quarter ending Q1 2026, Gross Margin fell 90849.0% year-over-year to 844.88%; the trailing twelve-month figure through Mar 2026 stood at 126.34% (up 1671.0% YoY), and the FY2025 full-year result was 81.14%, down 1868.0% from the prior year.
  • Gross Margin eased to 844.88% in Q1 2026, from 100.01% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 195.18% in Q4 2024 to a low of 8731.16% in Q2 2024.
  • A 5-year average of 932.61% and a median of 66.04% in 2023 frame the typical range for Gross Margin.
  • Peak annual rise in Gross Margin reached 880704 bps in 2025, while the deepest fall reached 668023 bps in 2025.
  • Tracing ZLAB's Gross Margin over 5 years: stood at 185.58% in 2022, then sank by 51 bps to 90.54% in 2023, then jumped by 116 bps to 195.18% in 2024, then sank by 49 bps to 100.01% in 2025, then tumbled by 945 bps to 844.88% in 2026.
  • Business Quant data shows ZLAB's Gross Margin at 844.88% in Q1 2026, 100.01% in Q4 2025, and 6580.57% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 88.95%
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 86.85%
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 91.79%
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 90.68%
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Zai Lab 21.37 Bn 21.37 Bn -34.26 Mn -844.88%

Historic Data

Download Data
DateValue
Mar 31, 2026 -844.88%
Dec 31, 2025 100.01%
Sep 30, 2025 -6,580.57%
Jun 30, 2025 75.89%
Mar 31, 2025 63.60%
Dec 31, 2024 195.18%
Sep 30, 2024 99.66%
Jun 30, 2024 -8,731.16%
Mar 31, 2024 100.00%
Dec 31, 2023 90.54%
Sep 30, 2023 63.20%
Mar 31, 2023 66.02%
Dec 31, 2022 185.58%
Sep 30, 2022 65.17%
Jun 30, 2022 63.87%
Mar 31, 2022 66.06%
Dec 31, 2021 50.63%
Jun 30, 2021 70.58%
Mar 31, 2021 62.67%
Dec 31, 2020 54.80%